Alcon Laboratories recalled Lot 10101 of Systane Lubricant Eye Drops Ultra PF due to fungal contamination, posing potential ...
The recall affects one lot of Systane Lubricant Eye Drops Ultra PF, sold in a 25-count box of single vials, which are used to ...
The Food and Drug Administration issued a nationwide recall of single-use eyedrops. One lot of Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, 25 count (Lot 10101) was recalled over ...
On Dec. 21, Alcon Laboratories issued a voluntary recall of one lot of its Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, 25-count (Lot 10101) after a consumer complaint revealed ...
The eye drops are typically used for temporary relief of burning and irritation for people with dry eye symptoms.
Alcon Laboratories has issued a recall for a specific lot of 'Systane Lubricant Eye Drops Ultra PF' due to potential fungal contamination. RECALL: Systane Lubricant Eye Drops Ultra PF in 25-count ...
The foreign material was found to be “fungal in nature” which can cause an eye infection that could threaten a person’s vision. It also can be potentially life-threatening. There have not been any ...
The eye drops, Systane Lubricant Eye Drops Ultra PF, are single vial drops available in a 25-count box and manufactured by Alcon Laboratories, based in Fort Worth, Texas. "Alcon evaluated a ...
The FDA announced Monday that Texas-based company Alcon Laboratories was voluntarily recalling one lot of Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go following a consumer ...
Alcon Laboratories in Fort Worth, Texas recalled one lot of Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, 25 count on December 21. The recall impacts Lot 10101 with an expiration ...
One lot of eye drops is being voluntarily recalled due to potential fungal contamination, the U.S. Food and Drug Administration announced earlier this week. The eye drops, Systane Lubricant Eye Drops ...
Systane brand eye drops were voluntarily recalled because of possible fungal contamination, the Food and Drug Administration said.